Table 2.
Potential ncRNA biomarkers from blood, plasma, or serum.
| ncRNA | Disease Association | Citations |
|---|---|---|
| miR-1224 | Acetaminophen injury * | [37] |
| miR-124 | ||
| miR-125a-3p | ||
| miR-125b-5p | ||
| miR-133a | ||
| miR-133b | ||
| miR-135a | ||
| miR-202-3p | ||
| miR-205 | ||
| miR-23a | ||
| miR-26a | ||
| miR-486 | ||
| miR-710 | ||
| miR-711 | ||
| miR-712 | ||
| miR-720 | ||
| miR-721 | ||
| miR-193 | Acetaminophen injury ^, Cirrhosis * | [37,77] |
| let-7d | Acetaminophen injury ^ | [37] |
| let-7g | ||
| miR-101b | ||
| miR-107 | ||
| miR-130a | ||
| miR-148a | ||
| miR-15a | ||
| miR-19b | ||
| miR-22 | ||
| miR-27b | ||
| miR-294 | ||
| miR-29a | ||
| miR-29c | ||
| miR-30a | ||
| miR-30c | ||
| miR-30e | ||
| miR-365 | ||
| miR-574-5p | ||
| miR-680 | ||
| miR-685 | ||
| miR-122 | Acetaminophen injury ^, Chronic hepatitis B ^ | [37,44] |
| miR-192 | Acetaminophen injury ^, NAFLD ^, NASH ^ | [37,78] |
| miR-21 | ||
| miR-29b | ||
| let-7e-5p | Chronic hepatitis B * | [44] |
| miR-125a-5p | ||
| miR-144-3p | ||
| miR-144-5p | ||
| miR-182-5p | ||
| miR-190a-5p | ||
| miR-454-3p | ||
| miR-7-5p | ||
| miR-99b-5p | ||
| miR-183-5p | Chronic hepatitis B *, NAFLD ^, NASH ^ | [44,78] |
| miR-215-5p | Chronic hepatitis B ^ | [44] |
| miR-224-5p | ||
| miR-320a | ||
| miR-335-5p | ||
| miR-584-5p | ||
| miR-625-3p | ||
| miR-146a-5p | ||
| miR-206 | ||
| miR-4433bb-3p | ||
| MEG3 (lncRNA) | Chronic hepatitis B-associated fibrosis * |
[79] |
| miR-152 | Cirrhosis * | [77] |
| miR-574-3p | ||
| miR-483-5p | Cirrhosis *, Acetaminophen injury *, Chronic hepatitis B ^ |
[37,44,77] |
| miR-451a | Cirrhosis ^, Acetaminophen injury *, Chronic hepatitis B * |
|
| miR-222-3p | Cirrhosis ^ | [77] |
| SCARNA10 | Fibrosis ^, cirrhosis ^ | [80] |
| circ_000520 | HCC * | [81] |
| circ_001565 | ||
| cSMARCA5 (circRNA) | ||
| miR-101-3p | [77] | |
| circ_0003731 | HCC ^ | [81] |
| circ_0008043 | ||
| circ_00244 | ||
| circ_0064428 | ||
| circ_0088030 | ||
| circ_104075 | ||
| circ-ZEB1.33 | ||
| let-7a-5p | [77] | |
| miR-128 | ||
| miR-139-5p | ||
| miR-320d | ||
| miR-382-5p | ||
| miR-423-5p | HCC ^, Chronic hepatitis B ^ | [44,77] |
| miR-126-5p | NAFLD ^, NASH ^ | [78] |
| miR-151a-3p | ||
| miR-15b-3p | ||
| miR-4449 | ||
| miR-214-3p | Steatosis * | [77] |
| miR-95 | ||
| miR-424-5p | Viral infection *, HCC * | [77] |
| miR-410 | Viral infection ^ | [77] |
* ncRNA is reduced in circulation; ^ ncRNA is increased in circulation.